EP3193913
ARGININE DEIMINASE WITH REDUCED CROSS-REACTIVITY TOWARD ADI - PEG 20 ANTIBODIES FOR CANCER TREATMENT
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
16.9.2015EP published:
11.5.2022EP application number:
15842576.9
EPO information:
European Patent Register
Max expiry date:
15.9.2035
Title in English:
ARGININE DEIMINASE WITH REDUCED CROSS-REACTIVITY TOWARD ADI - PEG 20 ANTIBODIES FOR CANCER TREATMENTLanguage of the patent:
English
Timeline
Today
16.9.2015EP application
11.5.2022EP Publication
Owner
Name:
Polaris GroupAddress:
P.O. Box 309 Ugland House, Grand Cayman, KY1-1104, KY
Inventor
Name:
SHOWALTER, RichardAddress:
El Cajun, California 92021, US
Name:
ALMASSY, RobertAddress:
Vista, California 92081, US
Name:
THOMSON, James A.Address:
San Diego, California 92123, US
Name:
SISSON, WesAddress:
San Diego, California 92127, US
Name:
SHIA, Wei-JongAddress:
San Diego, California 92126, US
Name:
CHEN, Li-ChangAddress:
San Diego, California 92121, US
Name:
LEE, YangAddress:
San Diego, California 92122, US
Priority
Number:
201462051182 PDate:
16.9.2014Country:
US
Classification
Categories:
A61K 38/50, A61K 47/60, A61P 35/00, A61K 45/06, C12N 9/78, A61P 35/02